Meng Xu

4.8k total citations · 2 hit papers
104 papers, 3.2k citations indexed

About

Meng Xu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Meng Xu has authored 104 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Molecular Biology, 36 papers in Cancer Research and 19 papers in Oncology. Recurrent topics in Meng Xu's work include MicroRNA in disease regulation (23 papers), Cancer-related molecular mechanisms research (16 papers) and Circular RNAs in diseases (14 papers). Meng Xu is often cited by papers focused on MicroRNA in disease regulation (23 papers), Cancer-related molecular mechanisms research (16 papers) and Circular RNAs in diseases (14 papers). Meng Xu collaborates with scholars based in China, United States and Australia. Meng Xu's co-authors include Cheng‐Xiong Xu, Wenzhi Bi, Hua Jin, Zhiqing Huang, Daiwen Chen, Bing Yu, Xiaoling Chen, Zhiyin Song, Heng Fan and Laurent Désaubry and has published in prestigious journals such as SHILAP Revista de lepidopterología, The EMBO Journal and Molecular Cell.

In The Last Decade

Meng Xu

101 papers receiving 3.1k citations

Hit Papers

PHB2 (prohibitin 2) promotes PINK1-PRKN/Parkin-dependent ... 2019 2026 2021 2023 2019 2023 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. PHB2 (prohibitin 2) promotes PINK1-PRKN/Parkin-dependent mitophagy by the PARL-PGAM5-PINK1 axis
    2019 301 citations Meng Xu, Zhiyin Song et al. profile →
  2. Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell
    2023 105 citations Xinhai Zhu, Meng Xu et al. Gut Microbes profile →

Peers

Meng Xu
Zakaria Y. Abd Elmageed United States
Zhen Wang China
Yugang Wang China
Fang Peng China
Tobias Schmid Germany
Yingjian Liang China
Ke Jiang China
Yanhong Zhou China
Diana Gulei Romania
Tong Liu China
Zakaria Y. Abd Elmageed United States
Meng Xu
Citations per year, relative to Meng Xu Meng Xu (= 1×) peers Zakaria Y. Abd Elmageed

Countries citing papers authored by Meng Xu

Since Specialization
Citations

This map shows the geographic impact of Meng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Xu more than expected).

Fields of papers citing papers by Meng Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Xu. The network helps show where Meng Xu may publish in the future.

Co-authorship network of co-authors of Meng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Meng Xu. A scholar is included among the top collaborators of Meng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng Xu. Meng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Wenjing, et al.. (2024). Effects of grape seed proanthocyanidin extract on cholesterol metabolism and antioxidant status in finishing pigs. Scientific Reports. 14(1). 21117–21117. 2 indexed citations
2.
Li, Yan, Xiang Zhan, Ying Song, et al.. (2023). Meta-analysis reveals Helicobacter pylori mutual exclusivity and reproducible gastric microbiome alterations during gastric carcinoma progression. Gut Microbes. 15(1). 2197835–2197835. 31 indexed citations
3.
4.
Wang, Zhen, Lei Liu, Lingfeng Yu, et al.. (2023). Circular RNA CircSATB2 facilitates osteosarcoma progression through regulating the miR-661/FUS-mediated mRNA of ZNFX1. Cellular Signalling. 114. 110977–110977. 2 indexed citations
5.
Xu, Meng, Ling Lin, Omprakash Shriwas, et al.. (2023). Heat shock factor 1 (HSF1) specifically potentiates c-MYC-mediated transcription independently of the canonical heat shock response. Cell Reports. 42(6). 112557–112557. 7 indexed citations
6.
He, Zirui, et al.. (2022). Development and Validation of a 7-Gene Inflammatory Signature Forecasts Prognosis and Diverse Immune Landscape in Lung Adenocarcinoma. Frontiers in Molecular Biosciences. 9. 822739–822739. 3 indexed citations
7.
Xu, Meng, et al.. (2022). AHNAK2 is a biomarker and a potential therapeutic target of adenocarcinomas. Acta Biochimica et Biophysica Sinica. 54(11). 1708–1719. 2 indexed citations
8.
Xu, Meng, He He, Jie Lin, et al.. (2021). ATAD3B is a mitophagy receptor mediating clearance of oxidative stress‐induced damaged mitochondrial DNA. The EMBO Journal. 40(8). e106283–e106283. 87 indexed citations
9.
Zhou, Qian, Tong Yang, Jin Liu, et al.. (2021). Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer. EMBO Molecular Medicine. 14(1). e14502–e14502. 42 indexed citations
10.
Li, Yin, Hao Sheng, Feng Ma, et al.. (2021). RNA m6A reader YTHDF2 facilitates lung adenocarcinoma cell proliferation and metastasis by targeting the AXIN1/Wnt/β-catenin signaling. Cell Death and Disease. 12(5). 479–479. 75 indexed citations
11.
Liu, Shupeng, et al.. (2019). <p>Irreversible electroporation combined with chemotherapy for unresectable pancreatic carcinoma: a prospective cohort study</p>. OncoTargets and Therapy. Volume 12. 1341–1350. 17 indexed citations
12.
13.
14.
Zhang, Lili, et al.. (2019). Modified Tong Xie Yao Fang relieves solitary rectal ulcer syndrome: A case report. World Journal of Clinical Cases. 7(15). 2058–2064. 2 indexed citations
15.
Dong, Yalan, Xueyun Duan, Yujin Liu, et al.. (2019). Autotaxin-Lysophosphatidic Acid Axis Blockade Improves Inflammation by Regulating Th17 Cell Differentiation in DSS-Induced Chronic Colitis Mice. Inflammation. 42(5). 1530–1541. 21 indexed citations
16.
Wang, Liang, et al.. (2015). microRNA-377 suppresses the proliferation of human osteosarcoma MG-63 cells by targeting CDK6. Tumor Biology. 36(5). 3911–3917. 23 indexed citations
17.
Xu, Meng, et al.. (2014). Decreased Expression of miR216a Contributes to Non–Small-Cell Lung Cancer Progression. Clinical Cancer Research. 20(17). 4705–4716. 51 indexed citations
18.
Xu, Meng, Hua Jin, Cheng‐Xiong Xu, Wenzhi Bi, & Yan Wang. (2014). MiR-34c inhibits osteosarcoma metastasis and chemoresistance. Medical Oncology. 31(6). 972–972. 50 indexed citations
19.
Xu, Meng, Zhigang Song, Cheng‐Xiong Xu, et al.. (2013). IL-17A Stimulates the Progression of Giant Cell Tumors of Bone. Clinical Cancer Research. 19(17). 4697–4705. 19 indexed citations
20.
Xu, Meng, et al.. (2008). [Effect of supplement energy and nourish lung herbs on drug-resistance lung cancer with mechanisms of mitochondrial and caspase signal].. PubMed. 31(9). 1396–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zakaria Y. Abd Elmageed Breakdown of academic impact, for papers by Zhen Wang Breakdown of academic impact, for papers by Yugang Wang Breakdown of academic impact, for papers by Fang Peng Breakdown of academic impact, for papers by Tobias Schmid Breakdown of academic impact, for papers by Yingjian Liang Breakdown of academic impact, for papers by Ke Jiang Breakdown of academic impact, for papers by Yanhong Zhou Breakdown of academic impact, for papers by Diana Gulei Breakdown of academic impact, for papers by Tong Liu
Rankless by CCL
2026